Steve Oswald
Analyst · B Riley Securities. Your line is open. Please go ahead
Well, thank you, Chris. And thanks everyone for joining us today for our second quarter conference call. Today, as usual, I'll give an update on the current situation of the company after which Chris Wampler, review our financials in detail. The company remains focused first and foremost on the health and safety of our employee's, team has done an excellent job with safety protocols put in place since March 2020. We continued to work with the authorities on best practices throughout our many operations. The total number of cases is roughly 214 since the beginning of the pandemic and within the company, we had 14 cases in Q2 2021. As mentioned in the press release Ducommun's second-quarter results were very strong, with the company's delivering year-over-year revenue growth of 9%, all organic, for the first time since Q1 2020. The Company's defense business continues to be a major success with momentum growing again year-over-year and was the main contributor to the quarter. The challenges in the commercial aerospace -- the aerospace market were overcome again by the team that we have seen some good signs for example with growth at Spirit Aerosystems in Q2, we're optimistic that we'll start seeing meaningful OEM build rate increases starting in 2022. In addition to revenue growth, we posted growth gross margins of 23% which is the highest level reached in 10 years of the company, along with adjusted EBITDA margins of 14.6%, which is an increase of 80 basis points year-over-year. The team also posted an adjusted operating income margin of 9% which is excellent progress, the quality of earnings was highest as well with the company reaching GAAP diluted EPS of $0.69 a share versus $0.43 of a share for Q2 2020 and adjusted diluted EPS of $0.74 a share versus $0.48 in 2020. These numbers reflect the return to revenue growth we anticipated along with strong operating management. This is all a great -- this is also a great story for our investors. And this quarter was a beginning of return to revenue growth for the full year of 2021 with the commercial aerospace market starting to recover in the quarters ahead. The company's second quarter revenue was higher with Ducommun's defense business. As mentioned earlier, leading the way being up 20% versus prior year. Our defense business revenues continued to show excellent progress on shipments and a robust business development approach. The majority of the gains in Q2 included the radar systems for Northrop Grumman, Raytheon TOW program, F18, Apache helicopter, UAVs General Atomics, Phalanx and other missile programs. Our approach to the market is innovative products and processes that provide significant value to the customer, along with striving for the highest level of service. The numbers show that we continued to be rewarded for this strategy. I also want to mention as I have in the past, the Raytheon Missile Defense business and the progress in signing -- since signing the strategic supplier agreement with them in July of 2019. We've been hard to work in three years. New programs offloading and share shifts. I'm happy to report that 2021 will be a record year overall with this legacy Raytheon business going from less than $90 million in 2020 to $115 million in 2021, an increase of more than 25%, what a great story. The defense results also show great opportunities when we leverage our structural product lines with defense OEMs. As previously mentioned, we have wins now in the TOW missile which was a share shift from another supplier and other new programs such as the Standard Missile to dorsal fin assembly, both for Raytheon Missile and Defense. Along with our acquisitions this part of the business will be north of $110 million in revenue for 2021 where it was under $80 million in 2019. Another defense structural highlight in Q2 was that Nobles Worldwide had secured significant contract to supply integrated ammunition handling systems as far the Stryker MCWS increase lethality program recently awarded to Oshkosh Defense. The total program over six years could be worth up to $943 million to Oshkosh and their partners. I have also overall still optimistic about defense opportunities for the Ducommun going forward. Spy concerns regarding the recent budget discussions in Washington and the change in administration. This is again to our value offering and still a modest revenue base. A good amount of runway is still ahead of us here at Ducommun. In regards to defense backlog, it remains strong and in Q2 with a backlog of $501 million. The commercial aerospace backlog also began to show some signs of recovery, increasing sequentially from $266 million at the end of Q1 to $276 million at the end of Q2. This is certainly a good sign. The total backlog was $814 million for the company and this is very good, it's a very good number based on the environment. Now, I want to take a few minutes to discuss my thoughts on a commercial aerospace business. We were notified in May with a press release approval on July that Ducommun is recognized an Airbus detailed parts partner and award long-term five-year contract. The commitment from the current industry leader allows us to provide a titanium-ware package for key products in the A320 and A330 programs. We were and are thrilled and honored to be awarded for the first time of D2P partner designation, which is a major accomplishment in Airbus representing a preferred supplier status along with a long-term five-year contract. This is a significant step forward for Ducommun and its industry leading titanium structural component business, to me is the highest level of endorsement and as I mentioned in the press release, a major milestone in the 172-year history of our company. This contract extends through 2026 and will provide many years of great value to Ducommun and its shareholders. The company's cost actions were also continuing to pay dividends. It certainly see that even before the pandemic, the company was working on initiatives offset the 737 MAX, the effectiveness of our operations -- operational leadership and action show the gross profit margins year-over-year and a solid operating income percentage along with the diluted EPS. I also want to mention our efforts on pricing. This is also having a positive impact on the company's financials. In regards to the outlook, our significant backlog in defense with the many growth programs mentioned earlier will provide good revenue in 2021. We estimate that revenue will be led by defense but over the quarters ahead, we'll see more commercial aerospace volume returned to Ducommun. We're also very well positioned with a high narrow-body to wide-body ratio for our business and have the capacity and strong operating team to deliver on the forecasted rate increases. With entire overall revenue growth this year anticipated Ducommun's total revenue to grow in the low to mid-single digits versus 2020. Future growth will be accomplished by leveraging our newly built-out defense business, strong positions in commercial aerospace especially on narrow-body revenues with Airbus, being a big part of our future as well as our three acquisitions, which continue to deliver. We also remain active in the market for M&A for new companies that fit our model and believe this will only be an accelerator to higher results. Now, let me provide some additional color on our markets, products and programs, beginning with our military and space sector, we posted second quarter revenue of $113 million once again representing strong organic growth versus 2020, up 20%. We drove revenue on some key defense platforms. As mentioned earlier, we saw increased demand for radar systems, Tow missile, F18 Apache helicopter, UAVs, Phalanx and other missile programs. The second quarter's military space revenue represented more than 70% of Ducommun's revenue in the period. We also continued to be very well positioned for further growth across defense platforms over the next several quarters in all sectors, especially at Raytheon. Again, ended the second quarter with a strong backlog of $501 million, which represents 62% of Ducommun's total backlog. Within our commercial aerospace operations, second-quarter revenue declined year-over-year to $37.6 million as expected driven by bill rate declines on a number of commercial aerospace platforms impacted by the COVID-19 pandemic. However, decline in revenue is not as sharp as in prior quarters. Call it also, an effective adjusted cost and management downturn and its well-positioned once rates stabilize and increase over the long term. Ducommun expects some meaningful improvement in this market in the second half of 2021 and as mentioned earlier, has a very bright future. The backlog within our commercial aerospace is roughly $276 million at the end of the second quarter, slight increased sequentially as I mentioned earlier compared to Q1. We stand ready with the team, processes and capital in place to support the expected bill rate increases in the next few years. And we are excited to get started. With that, I'll have Chris review our financial results in detail. Chris?